offers consulting services for publishers on content marketing, online publishing, search engine optimization, email newsletter marketing, editorial management, landing page best practices, social media optimization and online business management.
Saturday, October 24, 2015
Gastric Ulcers - Pipeline Review, H2 2015 - 5 Companies & 7 Drug Profiles
. Buy Fruit and Vegetable online Aristocort (Triamcinolone) with free Rx DUBLIN--(BUSINESS WIRE)--Research and Markets (.researchandmarkets.com/research/9l4hmd/gastric_ulcers)
has announced the addition of the "Gastric
Ulcers - Pipeline Review, H2 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Gastric Ulcers, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. http://doctor-answers.blogspot.com/ Buy Hansepran with free Rx Differin (Adapalen) It also
reviews key players involved in the therapeutic development for Gastric
Ulcers and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. Desyrel (Trazodone) with free Rx Buy Revatio (Sildenafil) without prescription It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
Astellas Pharma Inc.
ChoDang Pharm Co., Ltd.
Daewoong Pharmaceutical Co., Ltd.
Priaxon AG
Sihuan Pharmaceutical Holdings Group Ltd.
Drug Profiles
300-PXN-0040
Anaprazole Sodium
ASP-6537
DWJ-206
PMKS-005
PRD-007
Small Molecules for Gastric Ulcers
For more information visit .researchandmarkets.com/research/9l4hmd/gastric_ulcers
Monday, October 5, 2015
Houlihan Lokey Expands Healthcare Group with New Hire to Head Its Biopharma Practice
NEW YORK--(BUSINESS WIRE)--Houlihan Lokey (NYSE:HLI), the international investment bank, today
announced that Fedora Baloiu has joined the firm as Head of the
Biopharmaceutical practice in the firm’s Healthcare Group. Buy Azulfidine (Sulfasalazine) with no prescription Ms. Vesicare (Solifenacin) Baloiu
will be focusing on advising pharma, biotech and biopharma services and
technology clients globally. Buy Combivent (Ipratropium bromide / Albuterol sulfate) with free Rx She is based in New York, reporting to Mark
Francis, Managing Director and Head of the Healthcare Group.
Ms. About Fucidin with no Rx Baloiu joins from Goldman Sachs, where she has spent the last nine
years in the Healthcare group within the Investment Banking Division in
New York, focusing on pharmaceutical and biotech clients. Gestanin (Progestogen) with no Rx While at
Goldman, Ms. Buy Diarrhea and IBS online Baloiu worked on multiple M&A and financing transactions in
the biopharma space and spent 18 months in the London office. http://future-pharmaceuticals.blogspot.com Prior to
Goldman Sachs, she worked in Bain & Company’s Consumer and Healthcare
Group, providing strategic management consulting services to clients
throughout Europe. Over the course of her career, Ms. Baloiu has advised
on M&A and financing transactions with an aggregate value in excess of
$65 billion.
"We are delighted that Fedora is joining our healthcare team and we look
forward to collaborating with her to create significant success for
clients in the biopharmaceutical sector," said Mr. Francis. "Her client
relationships and depth of expertise in biopharmaceutical sector is
tremendously valuable in both U.S. and Europe, where we see a sustained
high level of M&A activity," he added.
"Houlihan Lokey s Healthcare Group has had tremendous success in
providing world class advice to clients and assisting them in achieving
market-leading outcomes. The Healthcare team has deep relationships with
strategics, financial sponsors, and financing sources and provides a
broad range of services and superior advice resulting in compelling
solutions for clients,” said Ms. Baloiu. "I am excited to join a
market-leading Healthcare team and I look forward to working with my
colleagues to continue the momentum the Group has achieved to date. I
expect the Biopharma and related services to continue the tremendous
growth experienced in recent years and I am eager to build upon such
opportunities with a leading team," she continued.
Houlihan Lokey has approximately 1,000 employees across 20 global
locations and is a long-term leader in the mid-cap M&A market. With over
30 dedicated banking professionals, Houlihan Lokey’s Healthcare Group is
among the largest in financial services. Following Ms. Baloiu’s hire,
the Group’s coverage capabilities span every vertical across the
healthcare sector. In 2014, the Group ranked #1 for US transactions
under $1 billion, according to Thomson Reuters.
Ms. Baloiu holds a B.A. in Finance from Bocconi University and an MBA
from Columbia Business School.
About Houlihan Lokey
Houlihan Lokey is an international investment bank with expertise in
mergers and acquisitions, capital markets, financial restructuring,
valuation, and strategic consulting. The firm serves corporations,
institutions, and governments worldwide with offices in the United
States, Europe, and the Asia-Pacific region. Independent advice and
intellectual rigor are hallmarks of our commitment to client success
across our advisory services. Houlihan Lokey is ranked as the No. 1 M&A
advisor for U.S. transactions under $5 billion, the No. 1 global
restructuring advisor, and the No. 1 M&A fairness opinion advisor for
U.S. transactions over the past 10 years, according to Thomson Reuters.
For more information, please visit .hl.com.
Subscribe to:
Posts (Atom)